Morgan Stanley Inst Inception C holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.
Morgan Stanley Institutional Fund, Inc. Inception Portfolio Class C MSCOX
- NAV / 1-Day Return 10.30 / −0.29 %
- Total Assets 221.9M
-
Adj. Expense Ratio
2.100%
- Expense Ratio 2.100%
- Distribution Fee Level Above Average
- Share Class Type Level Load
- Category Small Growth
- Investment Style Small Blend
- Min. Initial Investment 1,000
- Status Open
- TTM Yield 0.00
- Turnover 97%
USD | NAV as of Oct 02, 2026 | 1-Day Return as of Oct 02, 2026, 12:11 AM GMT+0
Morningstar’s Analysis MSCOX
Will MSCOX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 55.4
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Agilon Health Inc | 9.08 | 26M | Healthcare |
Cloudflare Inc | 8.93 | 25M | Technology |
Opendoor Technologies Inc Ordinary Shares - Class A | 7.37 | 21M | Real Estate |
Aurora Innovation Inc Class A | 6.56 | 19M | Consumer Cyclical |
IonQ Inc | 5.86 | 17M | Technology |
X4 Pharmaceuticals Inc | 3.81 | 11M | Healthcare |
HealthEquity Inc | 3.60 | 10M | Healthcare |
Celsius Holdings Inc | 3.53 | 10M | Consumer Defensive |
Immunovant Inc | 3.43 | 10M | Healthcare |
GRAIL Inc | 3.19 | 9M | Healthcare |